The first human patient has been injected with a ‘revolutionary’ cancer-killing virus known as Vaxinia, said scientists and added that it had been previously been used on animals successfully.
The scientists hope the virus will amplify the body’s immune system response to better fight against cancer cells, reports BGR.Vaxinia has been designed to kill cancer cells, producing promising results in previous animal trials.
In this recent trial, the researchers ensured that the virus was not only cancer-killing but also had the ability to make it more recognizable to the body’s immune system.
The vaccine is being tested in Phase 1 with a sample size of 100 patients with a metastatic or advanced solid tumour, who have already tried at least two other treatments.
